Adtalem Global Education (ATGE) AI Stock Analysis

• Market Cap: $3.56B
• Dividend Yield: N/A
• Average Volume (3M): 342.02K
• Price to Earnings (P/E): 15.8
• Beta (1Y): 0.80
• Revenue Growth: 12.85%
• EPS Growth: 81.69%
• Country: US
• Employees: 4,624
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Education & Training Services
• EPS (TTM): 1.75
• Shares Outstanding: 36,331,234
• 10 Day Avg. Volume: 255,787
• 30 Day Avg. Volume: 342,016
• PEG Ratio: 0.25
• Price to Book (P/B): 3.29
• Price to Sales (P/S): 2.64
• P/FCF Ratio: 16.65
• Enterprise Value/Market Cap: 0.00
• Enterprise Value/Revenue: 0.00
• Enterprise Value/Gross Profit: 0.00
• Enterprise Value/Ebitda: 0.00
• 1Y Price Target: $163.67
• Price Target Upside: 66.98% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3

• Rating: 67 Neutral
• Price Target: $106.00 ▲(8.14% Upside)

Adtalem Global Education's overall stock score is driven by strong earnings call performance and solid financials, despite technical indicators suggesting bearish momentum. The company's strategic initiatives and growth in enrollment provide a positive outlook, but technical and valuation concerns temper the score.

Positive Factors

Revenue Growth

The significant revenue growth indicates strong demand for Adtalem's educational offerings, supporting long-term business expansion and market presence.

Enrollment Growth

Consistent enrollment growth reflects the company's ability to attract students, ensuring stable revenue streams and reinforcing its competitive position.

Strategic Partnerships

Strategic partnerships enhance Adtalem's educational offerings, aligning with industry trends and increasing its value proposition in the healthcare sector.

Negative Factors

Chamberlain Enrollment Challenges

Enrollment challenges at Chamberlain could impact future revenue growth and highlight operational inefficiencies that need addressing.

Free Cash Flow Concerns

Negative free cash flow growth may hinder Adtalem's ability to invest in new initiatives or weather economic downturns, affecting long-term financial health.

Debt Levels

High debt levels can limit financial flexibility and increase risk, potentially impacting Adtalem's ability to fund growth or manage economic challenges.

Adtalem Global Education Business Overview & Revenue Model

Company Description

Adtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.

How the Company Makes Money

Adtalem Global Education generates revenue primarily through tuition and fees paid by students enrolled in its educational programs. The company operates several institutions, including medical and nursing schools, which often charge higher tuition rates due to the specialized nature of their programs. Additionally, ATGE earns revenue from online education offerings, adult and continuing education programs, and professional certification courses. The company may also benefit from partnerships with employers looking to upskill their workforce, as well as government funding for education programs. Financial aid and federal student loans are significant factors in driving enrollment and, consequently, revenue for the company.

Adtalem Global Education Financial Statement Overview

Summary

Adtalem Global Education demonstrates solid financial performance with consistent revenue growth and improved profitability margins. The balance sheet shows a positive trend in leverage management and return on equity. However, challenges in free cash flow growth and a moderately high debt-to-equity ratio suggest areas for improvement.

Income Statement

Adtalem Global Education has shown consistent revenue growth over the years, with a recent growth rate of 2.71%. The gross profit margin has remained strong, indicating efficient cost management. The net profit margin has improved significantly from negative figures in 2022 to a healthy 13.25% in 2025, reflecting enhanced profitability. EBIT and EBITDA margins have also shown positive trends, supporting overall profitability. However, the growth rate has slowed down compared to previous years, which could be a concern for future expansion.

Balance Sheet

The company's debt-to-equity ratio has improved over the years, indicating better leverage management, though it remains moderately high. Return on equity has increased to 16.54% in 2025, showcasing improved efficiency in generating profits from shareholders' equity. The equity ratio remains stable, suggesting a balanced capital structure. However, the company should continue to focus on reducing debt levels to further strengthen its financial position.

Cash Flow

Operating cash flow has increased, reflecting better cash generation from core operations. However, free cash flow growth has been negative recently, indicating potential challenges in maintaining liquidity. The operating cash flow to net income ratio is healthy, suggesting good cash conversion efficiency. The company should focus on improving free cash flow to ensure sustainable financial health.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.83B	1.79B	1.58B	1.45B	1.39B	899.25M
Gross Profit	799.03M	1.07B	886.10M	802.34M	722.07M	441.34M
EBITDA	404.25M	435.30M	335.56M	326.29M	264.45M	210.80M
Net Income	252.73M	237.06M	136.78M	93.36M	310.99M	70.03M
Balance Sheet
Total Assets	2.87B	2.75B	2.74B	2.81B	3.03B	3.05B
Cash, Cash Equivalents and Short-Term Investments	264.69M	199.60M	219.31M	272.19M	346.97M	476.38M
Total Debt	775.95M	774.00M	847.85M	896.19M	1.07B	1.29B
Total Liabilities	1.41B	1.32B	1.37B	1.35B	1.52B	1.75B
Stockholders Equity	1.46B	1.43B	1.37B	1.46B	1.51B	1.30B
Cash Flow
Free Cash Flow	323.28M	287.57M	246.88M	165.90M	-20.63M	143.53M
Operating Cash Flow	379.21M	337.90M	295.77M	202.91M	10.42M	192.20M
Investing Cash Flow	-48.41M	-41.92M	-47.85M	23.74M	-551.63M	-56.69M
Financing Cash Flow	-331.41M	-316.02M	-301.80M	-288.51M	-424.48M	676.47M

Adtalem Global Education Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 98.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATGE, the sentiment is Negative. The current price of 98.02 is below the 20-day moving average (MA) of 146.12, below the 50-day MA of 142.40, and below the 200-day MA of 120.16, indicating a bearish trend. The MACD of -2.81 indicates Positive momentum. The RSI at 16.20 is Positive, neither overbought nor oversold. The STOCH value of 10.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATGE.

Adtalem Global Education Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STRA	―	$1.82B	15.80	6.89%	3.16%	4.31%	-1.08%
LAUR	―	$4.28B	17.12	20.15%	―	0.44%	35.19%
PRDO	―	$2.29B	15.03	16.39%	1.70%	15.99%	13.25%
LOPE	―	$5.29B	22.82	30.77%	―	6.52%	11.72%
GHC	―	$4.42B	6.05	17.20%	0.71%	4.13%	228.37%
ATGE	―	$3.56B	15.82	16.60%	―	12.85%	81.69%
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Adtalem Global Education Corporate Events

Adtalem Global Education Reports Strong Growth Amid Challenges

Adtalem Global Education’s recent earnings call conveyed a positive sentiment, highlighting robust performance and growth, particularly at Walden University. The company demonstrated significant improvements in key financial metrics, although challenges at Chamberlain University were acknowledged. Despite these hurdles, Adtalem remains optimistic about its strategic direction and long-term growth potential.

Adtalem Global Education Reports Strong Q1 Performance

Adtalem Global Education is a leading provider of healthcare education in the United States, offering a wide range of academic programs aimed at preparing a skilled workforce for the healthcare industry.

Adtalem Announces Retirement of Chamberlain University President

On October 6, 2025, Adtalem Global Education announced the retirement of Dr. Karen Cox, President of Chamberlain University, after nearly 40 years in healthcare and nursing education. Under her leadership since 2018, Chamberlain University became the largest school of nursing in the U.S., significantly expanding its student base and strengthening its position as a leading grantor of Bachelor of Science in Nursing degrees. The company has initiated an external search for her successor, highlighting the impact of her tenure on the institution’s growth and commitment to academic excellence.

The most recent analyst rating on (ATGE) stock is a Buy with a $172.00 price target. To see the full list of analyst forecasts on Adtalem Global Education stock, see the ATGE Stock Forecast page.

Adtalem Global Education Amends Credit Agreement for Growth

On August 6, 2025, Adtalem Global Education Inc. announced an amendment to its credit agreement, increasing its revolving facility by $100 million and extending its maturity to 2030. The company reported exceptional fiscal year 2025 results, with a 12.9% increase in revenue and a 33.1% growth in adjusted earnings per share. Total enrollment grew by 10.2% year-over-year, driven by strong performances from Chamberlain and Walden Universities. Adtalem’s strategic initiatives, including partnerships and program accreditations, are positioning it for sustained growth and impact in the healthcare education sector.

The most recent analyst rating on (ATGE) stock is a Buy with a $84.00 price target. To see the full list of analyst forecasts on Adtalem Global Education stock, see the ATGE Stock Forecast page.